Atlas Trials

Efficacy and Tolerance of Solriamfetol in Patients Affected with Idiopathic Hypersomnia.

Clinical trial NCT06590662 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06590662
Sponsor
University Hospital, Montpellier
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Idiopathic Hypersomnia
Start date
2024-09-15
Primary completion
2026-11-15
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.